Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1982 Apr;13(4):539–541. doi: 10.1111/j.1365-2125.1982.tb01418.x

The addition of prazosin to standard triple therapy in the treatment of severe hypertension.

A M Heagerty, G I Russell, R F Bing, H Thurston, J D Swales
PMCID: PMC1402042  PMID: 7066169

Abstract

1 A small dose of prazosin was added to the treatment regime of sixteen hypertensive patients poorly controlled on a combination of bendrofluazide, hydralazine and propranolol. 2 There was a significant improvement in blood pressure control in all patients at 1 month (P less than 0.01) and this was maintained at 9 months (P less than 0.02). Tolerance to prazosin was not a problem. 3 The addition of prazosin to conventional triple drug therapy produces a further useful fall in blood pressure.

Full text

PDF
539

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson A. B., Robertson J. I. Captopril in the treatment of clinical hypertension and cardiac failure. Lancet. 1979 Oct 20;2(8147):836–839. doi: 10.1016/s0140-6736(79)92186-x. [DOI] [PubMed] [Google Scholar]
  2. Awan N. A., Miller R. R., Maxwell K., Mason D. T. Effects of prazosin on forearm resistance and capacitance vessels. Clin Pharmacol Ther. 1977 Jul;22(1):79–84. doi: 10.1002/cpt197722179. [DOI] [PubMed] [Google Scholar]
  3. Bing R. F., Russell G. I., Thurston H., Swales J. D. Hydrallazine in hypertension: is there a safe dose? Br Med J. 1980 Aug 2;281(6236):353–354. doi: 10.1136/bmj.281.6236.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Graham R. M., Thornell I. R., Gain J. M., Bagnoli C., Oates H. F., Stokes G. S. Prazosin: the first-dose phenomenon. Br Med J. 1976 Nov 27;2(6047):1293–1294. doi: 10.1136/bmj.2.6047.1293. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hua A. S., Macdonald I. M., Myers J. B., Fang P., Kincaid-Smith P. Studies with prazosin--a new effective hypotensive agent. II. Two double-blind cross-over studies comparing the effects of prazosin and hydrallazine. Med J Aust. 1977 Jul 2;2(1):5–9. [PubMed] [Google Scholar]
  6. Marshall A. J., Barritt D. W., Pocock J., Heaton S. T. Evaluation of beta blockade bendrofluazide, and prazosin in severe hypertension. Lancet. 1977 Feb 5;1(8006):271–274. doi: 10.1016/s0140-6736(77)91822-0. [DOI] [PubMed] [Google Scholar]
  7. Packer M., Meller J., Gorlin R., Herman M. V. Hemodynamic and clinical tachyphylaxis to prazosin-mediated afterload reduction in severe chronic congestive heart failure. Circulation. 1979 Mar;59(3):531–539. doi: 10.1161/01.cir.59.3.531. [DOI] [PubMed] [Google Scholar]
  8. Pettinger W. A. Minoxidil and the treatment of severe hypertension. N Engl J Med. 1980 Oct 16;303(16):922–926. doi: 10.1056/NEJM198010163031607. [DOI] [PubMed] [Google Scholar]
  9. Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. A cooperative study. JAMA. 1977 Jan 17;237(3):255–261. [PubMed] [Google Scholar]
  10. Taguchi J., Freis E. D. Partial versus complete control of blood pressure in the prevention of hypertensive complications. Circ Res. 1975 Jun;36(6 Suppl 1):257–260. doi: 10.1161/01.res.36.6.257. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES